Weyerer S, Dilling H
Central Institute of Mental Health, Mannheim, University of Munich, Germany.
J Clin Epidemiol. 1991;44(3):303-11. doi: 10.1016/0895-4356(91)90042-8.
In the Upper Bavarian Field Study a total of 1536 persons (15 years and older) were interviewed by research psychiatrists. 8.1% of all respondents took a psychotropic drug during the 7 days prior to the interview. The consumption rate among women was about three times as high as that for men. The use of psychotropic drugs increased with age. No consistent pattern was found with respect to social class. According to psychiatric/physical health status the highest consumption rate (29.4%) was found among those suffering solely from psychiatric disorders. The simultaneous occurrence of both psychiatric and physical disorder did not increase the risk of drug taking (21.4%). Less than 5% of the healthy respondents and of those suffering solely from a physical disorder used psychotropic drugs. A large proportion (63.0%) of those with previous psychiatric in- and outpatient treatment received psychotropic medication, as well as those suffering from schizophrenia (66.7%), affective psychoses (52.6%) and anxiety disorders (50.0%). The higher consumption of psychotropic drugs among women could not be explained by higher psychiatric or physical morbidity or the fact that women consult primary care physicians more frequently than do men. Controlling for co-morbidity and annual consultation of family physicians, significant sex differences in the consumption of psychotropic drugs persist.
在上巴伐利亚实地研究中,研究精神病医生共对1536人(15岁及以上)进行了访谈。在接受访谈前的7天内,所有受访者中有8.1%服用了精神药物。女性的服药率约为男性的三倍。精神药物的使用随年龄增长而增加。在社会阶层方面未发现一致的模式。根据精神/身体健康状况,仅患有精神疾病的人群中服药率最高(29.4%)。精神疾病和身体疾病同时存在并未增加服药风险(21.4%)。健康受访者和仅患有身体疾病的受访者中,使用精神药物的比例不到5%。很大一部分(63.0%)曾接受过精神科门诊和住院治疗的人服用了精神药物,精神分裂症患者(66.7%)、情感性精神病患者(52.6%)和焦虑症患者(50.0%)也是如此。女性精神药物服用率较高,这无法用更高的精神或身体发病率,或女性比男性更频繁地咨询初级保健医生这一事实来解释。在控制了合并症和家庭医生的年度咨询次数后,精神药物消费方面的显著性别差异依然存在。